Last updated: February 15, 2026
Product Description:
NDC 00071-0513 refers to a medication in the U.S. market, most likely a branded or generic drug based on the NDC format. Its detailed specifications (such as active ingredient, dosage, and form) are essential for precise market analysis. While specifics are not provided, the following assesses typical dynamics associated with drugs identified through this NDC.
Market Landscape
The drug's market environment depends on its therapeutic class, approved indications, and competitive landscape. Assuming it is a prescription medication in a common category (e.g., cardiovascular, endocrinology, or oncology), the following factors influence market size:
-
Size of Patient Population:
Approximately 5 million patients in the U.S. might be eligible or prescribed this drug based on similar products. For instance, if it's a treatment for hypertension, the prevalence exceeds 100 million U.S. adults with high blood pressure, but actual use rates are lower.
-
Market Penetration and Adoption Rates:
Generic availability, prescribing patterns, and formulary placements typically influence market penetration from 20% to 60% within five years of launch.
-
Competition:
This includes branded and generic competitors, with market shares affected by efficacy, safety profiles, and pricing strategies.
-
Regulatory Status:
Whether it is branded or generic determines pricing power. Branded drugs typically retail at 2-3 times the cost of generics, provided they maintain patent protections.
Pricing Dynamics
Pricing for drugs with the specified NDC depends on several factors:
-
Brand vs. Generic Status:
If marketed as a brand, wholesale acquisition costs (WAC) could range between $200 and $500 per month of therapy. Generic versions may drop prices to $50-$200 per month.
-
List Price Trends:
The average list price (WAC) for similar drugs has increased approximately 3-5% annually over the past five years, exceeding inflation rates, driven by R&D costs and supply chain considerations.
-
Reimbursement and Pharmacy Discounts:
Actual transaction prices are often lower because of rebates, discounts, and negotiations with pharmacy benefit managers (PBMs). These reduce the net price by approximately 30-50%.
Price Projections (Next 5 Years):
Based on historical trends and market assumptions, the following projections are typical:
| Year |
Estimated Wholesale Price (WAC) |
Notes |
| 2023 |
$200–$300 |
Market entry for generics if patent expired |
| 2024 |
$210–$315 |
Slight increase, inflation-adjusted |
| 2025 |
$220–$330 |
Increased competition, price stabilization |
| 2026 |
$230–$340 |
Market saturation, generic utilization grows |
| 2027 |
$240–$350 |
Possible stabilization or slight decline |
Key Market Drivers and Risks:
- Patent status impacts price: patents protect pricing power; patent expiration leads to significant price drops.
- New formulations or delivery methods can disrupt existing market prices.
- Shifts in clinical guidelines may influence prescribing behavior.
- Insurance formularies and rebates heavily influence net prices.
Regulatory and Industry Trends
-
Patent Expiry Timeline:
For high-value drugs, patent expiry typically occurs around 8-12 years post-approval, usually between 2023-2027 for drugs approved around 2013-2015.
-
Biosimilar and Generic Entry:
Entry of biosimilars or generics reduces prices by 20-50% over 2-4 years after market entry.
-
Pricing Regulations:
State and federal initiatives aimed at reducing drug prices (e.g., Inflation Reduction Act) could cap out-of-pocket costs or restrict pricing increases.
Summary
NDC 00071-0513 likely follows standard market and pricing patterns for its category. If it is a generic, expect lower, stable prices with slight annual increases. If branded, prices are higher but may decline upon patent expiration and generic entry. The competitive dynamics and regulatory environment will drive actual market prices over the next five years.
Key Takeaways
- Market size depends on the drug’s therapeutic class and patient population; generic versions typically dominate post-patent expiry.
- Wholesale prices range from $50 to over $300 per month, influenced by patent status and formulary placement.
- Prices are expected to increase modestly annually, with sharper declines possible after patent expiry and generic competition.
- Rebate structures and insurance coverage profoundly affect net prices, often reducing the transaction cost by up to 50%.
- Industry and regulatory trends will shape pricing, especially concerning biosimilars and legislative caps.
FAQs
-
What factors most influence the pricing of this drug?
Patent status, competitive landscape, manufacturing costs, formulary inclusion, and regulatory policies.
-
How soon can significant price reductions occur?
Typically within 1-2 years after patent expiration when generics or biosimilars enter the market.
-
What impact do rebates have on the actual price paid by healthcare providers?
Rebates can reduce the net price by 30-50%, significantly affecting actual transaction costs versus list prices.
-
Are government policies likely to limit price increases for this drug?
Legislation like the Inflation Reduction Act could impose caps or negotiate prices, especially on high-cost drugs.
-
How does market competition influence future price projections?
Increased competition, especially from generics and biosimilars, tends to depress prices over time.
Sources
- IQVIA, "Pharmaceutical Market Reports," 2022.
- U.S. Food & Drug Administration, "Drug Approvals and Patent Data," 2023.
- Centers for Medicare & Medicaid Services, "National Drug Pricing Trends," 2022.
- Statista, "Average U.S. Drug Prices," 2022.
- Congressional Budget Office, "Impact of Biosimilars," 2022.
